WO2010017586A1 - Inhaler with piercable vial and drug in liquid form - Google Patents
Inhaler with piercable vial and drug in liquid form Download PDFInfo
- Publication number
- WO2010017586A1 WO2010017586A1 PCT/AU2009/001029 AU2009001029W WO2010017586A1 WO 2010017586 A1 WO2010017586 A1 WO 2010017586A1 AU 2009001029 W AU2009001029 W AU 2009001029W WO 2010017586 A1 WO2010017586 A1 WO 2010017586A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drug
- vial
- barrel
- piercing means
- mouthpiece
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
- A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/0035—Piercing means
- A61M15/0036—Piercing means hollow piercing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/0087—Environmental safety or protection means, e.g. preventing explosion
- A61M16/009—Removing used or expired gases or anaesthetic vapours
- A61M16/0093—Removing used or expired gases or anaesthetic vapours by adsorption, absorption or filtration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/105—Filters
- A61M16/106—Filters in a path
- A61M16/1065—Filters in a path in the expiratory path
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0468—Liquids non-physiological
- A61M2202/048—Anaesthetics
Definitions
- the invention described herein relates generally to a device and method for the administration of volatile drugs in liquid form.
- the invention is directed to a device and method for inhalation administration of volatile drugs in liquid form, although the scope of the invention is not necessarily limited thereto.
- Opioid analgesics are known to have the potential to cause dependency, and are therefore not always the drug of choice for these medical circumstances.
- Intravenous administration is a difficult mode of administration under many conditions, including for example emergency roadside incidents, non-compliant patients, or non-sterile environments.
- a further device which is a hand-held device, currently available in at least
- the invention provides a device for facilitating inhalation of an inhalable drug in liquid form, the device comprising a barrel for holding a vial of the inhalable drug in liquid form, a piercing means substantially in the barrel, and a mouthpiece attached to an end of the barrel.
- the invention provides a method of providing an inhalable drug in liquid form comprising inserting a vial of the drug into the barrel of the device of the first embodiment, piercing the seal of the vial with the piercing means, applying the mouthpiece to a subject wherein the subject inhales through the mouthpiece the drug released upon piercing of the seal.
- the drug can be any inhalable drug in liquid form that is sufficiently volatile to be available for inhalation upon release from the vial.
- the device is particularly suited to drugs such as analgesics, including but not limited to inhalable fiuorocarbon-based analgesics such as sevoflurane, methoxyflurane, desflurane, isoflurane, enfiurane, diethyl ether, methoxypropane, chloroform, and halothane.
- the barrel of the device can be any configuration which will accommodate a vial of inhalable drug in liquid form.
- the barrel is a substantially straight tube, or a tube including a substantially right angled bend towards the mouthpiece.
- the vial can be a standard commercially available vial, or a vial made specifically for the device of the invention.
- the vial is a standard 1-5OmL vial.
- the device of the invention can be a disposable, single-use device, or can be configured for repeated use.
- the barrel can be configured such that the vial is sealed inside the barrel upon manufacture of the device, or the barrel can be configured to reversibly open at one end to receive a vial when needed.
- the latter option can include any practicable reversible opening means, including a screw-type device, clip device or snap-lock device.
- the piercing means can be any means capable of piercing the seal of a drug vial.
- the piercing means is a plastic needle-type device, attached near to the vial end inside the barrel.
- the piercing means preferably is an integral part of the barrel moulding itself. When the vial is moved towards the piercing means, this can be effected in any practicable manner.
- the barrel has a rotatable actuator mechanism in contact with the base of the vial which, when twisted, forces the vial along the barrel until the piercing means pierces the seal of the vial.
- the piercing means can be moved towards the seal of the vial.
- the barrel can have any practicable mechanism for activation to move the needle towards the piercing means, such as a depressable actuator or more than one depressable actuators on the exterior of the device which, when depressed, moves the needle towards the seal of the vial and forces the needle to pierce that seal.
- the device of the invention can also include a wick of any practicable material inside the barrel. Upon piercing of the seal of the vial, the contents of the vial run or disperse onto the wick, increasing the available surface area for active evaporation. This assists vaporization and retention of the drug for inhalation.
- the mouthpiece is attached to an end of the barrel by any means, and can be fixed or movable. If the mouthpiece is movable, which is generally when the barrel is a straight tube, preferably that mouthpiece is movable through approximately 180°, allowing the subject to access the mouthpiece and thereby the drug from any body position or recline.
- the mouthpiece can also be fitted into a standard medical mask to assist with administration of the drug to an incapacitated patient.
- the device can also include a filter in communication with the mouthpiece.
- the filter can be located in any practicable position on the device but is preferably located in an exhalation port on the barrel of the device.
- the filter can be made any material capable of absorbing vapours of the inhalable drug in liquid form.
- the filter is preferably made of activated carbon matrix or another equivalent solvent-retaining medium.
- the device of the invention can be made of any practicable material but is preferably made from solvent-resistant plastic.
- the device can be any colour, including different colours to indicate the nature of the inhalable drug in liquid form in the vial in the barrel of the device.
- the device can also be colourless or coloured translucent plastic so that the level of drug in the vial in the barrel of the device is visible.
- the material of manufacture can also have an additive to render the device able to glow in the dark. This would assist patients and care providers in emergency situations where lighting is not available.
- the device of the invention can also include a strap reversibly or irreversibly attached to any practicable position on the barrel.
- the strap can be intended for use around the wrist or neck of a patient.
- the strap is preferably attached to the end of the barrel furthest from the mouthpiece.
- the strap is preferably attached by one or more snap- tag to prevent trapping or strangulation of the patient.
- the snap-tag can be easily removed with a sharp pull to release the strap from the barrel.
- the device can also include a nozzle or port on the barrel for attachment of a medical standard oxygen hose if required.
- Figure 1 is a representation of a first embodiment of the device showing internal and external features.
- Figure 2 is a perspective view of the external features of a first embodiment of the device.
- Figure 3 is a top view of the external features of a first embodiment of the device.
- Figure 4 is a side view of the external features of a first embodiment of the device.
- Figure 5 is a top view of the external features of a second embodiment of the device.
- Figure 6 is a side view of the external features of a second embodiment of the device.
- Figure 7 is an exploded view of a second embodiment of the device.
- DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS Figures 1 to 4 refer to a first embodiment of the invention.
- FIG. 1 which shows internal and external features of the device (1)
- the vial (2) containing the inhalable drug in liquid form is loaded in the barrel (3) of the device.
- any wastage or potentially harmful spillage of the drug is avoided. This also ensures that the patient dose is accurately known.
- the actuator (4) is turned, forcing the seal of the vial (2) onto a piercing means (5).
- the piercing means (5) pierces the seal of the vial (2) and releases the drug in the barrel (3) and onto a wick (not shown).
- the patient places the mouth around the mouthpiece (6), which can be swiveled around an axis (7). This function of the mouthpiece allows for administration of the drug to a patient in any physical position.
- the patient then inhales through the mouthpiece (6), inhalation made possible by inlet air vents included in the actuator section (8).
- the snap-tags (10) for attachment of a strap are shown in the Figures, as is the optional nozzle (11) for attachment of an oxygen hose.
- Figures 5 to 7 refer to a second embodiment of the invention.
- the vial (12) containing the inhalable drug in liquid form is loaded in the barrel (13) of the device.
- the sealed vial By loading the sealed vial into the barrel, any wastage or potentially harmful spillage of the drug is avoided. This also ensures that the patient dose is accurately known.
- the depressable actuators (14) are depressed and the piercing means (15) pierces the seal of the vial (12) and releases the drug in the barrel (13).
- Figure 7 represents the piercing means (15) after piercing the vial seal.
- the patient places the mouth around the mouthpiece (16), which is at the end of a substantially right angle in the barrel, furthest from the depressable actuators. This position of the mouthpiece allows for administration of the drug to a patient in any physical position. The patient then inhales through the mouthpiece (16), inhalation made possible by inlet air vents included in the actuator portion (17).
- any remaining drug is absorbed by the filter (18) in the outlet vents (not shown) in the actuator portion (17), thereby preventing escape of any drug into the environment of the patient and caregiver.
- Attachment of a strap is preferably on the side of the mouthpiece (20), opposite the air inlet (see Figure 6).
- the optional nozzle (19) for attachment of an oxygen hose is also shown in the Figures.
- the invention therefore provides a novel and efficient way of administering an inhalable drug in liquid form to a patient, without wastage or spillage of the drug, contamination of the surroundings, or discomfort to the patient.
- the device also provides a portable administration unit which is easy to operate, allowing a patient to self-administer should the need arise.
- the device can be disposable which improves the safety and reproducibility of administration of the drug.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Environmental Sciences (AREA)
- Ecology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Environmental & Geological Engineering (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
The invention provides a device for facilitating inhalation of an inhalable drug in liquid form comprising a barrel for holding a vial of the drug, a piercing means substantially in the barrel, and a mouthpiece attached to an end of the barrel, and a method of providing an inhalable drug in liquid form using the device of the invention.
Description
INHALER WITH PIERCABLE VIAL AND DRUG IN LIQUID FORM
TECHNICAL FIELD
The invention described herein relates generally to a device and method for the administration of volatile drugs in liquid form. In particular, the invention is directed to a device and method for inhalation administration of volatile drugs in liquid form, although the scope of the invention is not necessarily limited thereto.
BACKGROUND ART
In many medical circumstances, there is a need for rapid onset of analgesia. This is generally achieved by intravenous administration of opioid-based analgesics. There are many disadvantages associated both with the drugs used and with the method of administration.
Opioid analgesics are known to have the potential to cause dependency, and are therefore not always the drug of choice for these medical circumstances. Intravenous administration is a difficult mode of administration under many conditions, including for example emergency roadside incidents, non-compliant patients, or non-sterile environments.
The use of inhalation anesthetics has been contemplated for use in analgesia. There are devices which administer for example sevoflurane and methoxyflurane for inhalation, but these suffer from several disadvantages.
The device disclosed in PCT/US02/33190 administers the drug using compressed air/oxygen is cumbersome, expensive and not easily portable.
A further device which is a hand-held device, currently available in at least
Australia, suffers from the severe drawback that the drug has to be poured into the barrel of the device for administration. This pouring action easily results in spillage on the skin of the medical carer or patient, and release of the drug into the air space around these people, which is dangerous and inefficient as the actual dosage is then unknown.
Therefore, there would be an advantage if it were possible to provide a device for administration of inhalable drugs which may overcome at least some of the above- mentioned disadvantages or provide a useful or commercial choice.
SUMMARY OF THE INVENTION In a first embodiment, the invention provides a device for facilitating inhalation of an inhalable drug in liquid form, the device comprising a barrel for holding a vial of the inhalable drug in liquid form, a piercing means substantially in the barrel, and a mouthpiece attached to an end of the barrel.
In a second embodiment, the invention provides a method of providing an inhalable drug in liquid form comprising inserting a vial of the drug into the barrel of the device of the first embodiment, piercing the seal of the vial with the piercing means, applying the mouthpiece to a subject wherein the subject inhales through the mouthpiece the drug released upon piercing of the seal.
With regard to the first and second embodiments as defined above, the drug can be any inhalable drug in liquid form that is sufficiently volatile to be available for inhalation upon release from the vial. The device is particularly suited to drugs such as analgesics, including but not limited to inhalable fiuorocarbon-based analgesics such as sevoflurane, methoxyflurane, desflurane, isoflurane, enfiurane, diethyl ether, methoxypropane, chloroform, and halothane. The barrel of the device can be any configuration which will accommodate a vial of inhalable drug in liquid form. Preferably the barrel is a substantially straight tube, or a tube including a substantially right angled bend towards the mouthpiece. The vial can be a standard commercially available vial, or a vial made specifically for the device of the invention. Preferably the vial is a standard 1-5OmL vial. The device of the invention can be a disposable, single-use device, or can be configured for repeated use. To this end, the barrel can be configured such that the vial is sealed inside the barrel upon manufacture of the device, or the barrel can be configured to reversibly open at one end to receive a vial when needed. The latter option can include any practicable reversible opening means, including a screw-type device, clip device or snap-lock device.
The piercing means can be any means capable of piercing the seal of a drug vial. Preferably the piercing means is a plastic needle-type device, attached near to the vial end inside the barrel. The piercing means preferably is an integral part of the barrel moulding itself. When the vial is moved towards the piercing means, this can be effected in any practicable manner. Preferably the barrel has a rotatable actuator mechanism in contact with the base of the vial which, when twisted, forces the vial along the barrel until the piercing means pierces the seal of the vial.
Alternatively, the piercing means can be moved towards the seal of the vial. In this embodiment, the barrel can have any practicable mechanism for activation to move the needle towards the piercing means, such as a depressable actuator or more than one depressable actuators on the exterior of the device which, when depressed, moves the needle towards the seal of the vial and forces the needle to pierce that seal.
The device of the invention can also include a wick of any practicable material inside the barrel. Upon piercing of the seal of the vial, the contents of the vial run or disperse onto the wick, increasing the available surface area for active evaporation. This assists vaporization and retention of the drug for inhalation.
The mouthpiece is attached to an end of the barrel by any means, and can be fixed or movable. If the mouthpiece is movable, which is generally when the barrel is a straight tube, preferably that mouthpiece is movable through approximately 180°, allowing the subject to access the mouthpiece and thereby the drug from any body position or recline. The mouthpiece can also be fitted into a standard medical mask to assist with administration of the drug to an incapacitated patient.
The device can also include a filter in communication with the mouthpiece. The filter can be located in any practicable position on the device but is preferably located in an exhalation port on the barrel of the device. The filter can be made any material capable of absorbing vapours of the inhalable drug in liquid form. The filter is preferably made of activated carbon matrix or another equivalent solvent-retaining medium.
The device of the invention can be made of any practicable material but is preferably made from solvent-resistant plastic. The device can be any colour, including different colours to indicate the nature of the inhalable drug in liquid form in the vial in
the barrel of the device. The device can also be colourless or coloured translucent plastic so that the level of drug in the vial in the barrel of the device is visible. The material of manufacture can also have an additive to render the device able to glow in the dark. This would assist patients and care providers in emergency situations where lighting is not available.
The device of the invention can also include a strap reversibly or irreversibly attached to any practicable position on the barrel. The strap can be intended for use around the wrist or neck of a patient. The strap is preferably attached to the end of the barrel furthest from the mouthpiece. The strap is preferably attached by one or more snap- tag to prevent trapping or strangulation of the patient. The snap-tag can be easily removed with a sharp pull to release the strap from the barrel.
The device can also include a nozzle or port on the barrel for attachment of a medical standard oxygen hose if required.
In order that the invention may be more readily understood and put into practice, one or more preferred embodiments thereof will now be described, by way of example only, with reference to the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a representation of a first embodiment of the device showing internal and external features. Figure 2 is a perspective view of the external features of a first embodiment of the device.
Figure 3 is a top view of the external features of a first embodiment of the device. Figure 4 is a side view of the external features of a first embodiment of the device.
Figure 5 is a top view of the external features of a second embodiment of the device.
Figure 6 is a side view of the external features of a second embodiment of the device.
Figure 7 is an exploded view of a second embodiment of the device.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS Figures 1 to 4 refer to a first embodiment of the invention.
Referring firstly to Figure 1 , which shows internal and external features of the device (1), the vial (2) containing the inhalable drug in liquid form is loaded in the barrel (3) of the device. By loading the sealed vial into the barrel, any wastage or potentially harmful spillage of the drug is avoided. This also ensures that the patient dose is accurately known.
The actuator (4) is turned, forcing the seal of the vial (2) onto a piercing means (5). The piercing means (5) pierces the seal of the vial (2) and releases the drug in the barrel (3) and onto a wick (not shown).
The patient places the mouth around the mouthpiece (6), which can be swiveled around an axis (7). This function of the mouthpiece allows for administration of the drug to a patient in any physical position.
Referring also to Figures 2 and 4, the patient then inhales through the mouthpiece (6), inhalation made possible by inlet air vents included in the actuator section (8).
Upon exhalation, any remaining drug is absorbed by the filter (not shown) in the outlet vents (9), thereby preventing escape of any drug into the environment of the patient and caregiver.
The snap-tags (10) for attachment of a strap are shown in the Figures, as is the optional nozzle (11) for attachment of an oxygen hose.
Figures 5 to 7 refer to a second embodiment of the invention.
Referring to the exploded view of the second embodiment, Figure 7, which shows internal and external features of the device, the vial (12) containing the inhalable drug in liquid form is loaded in the barrel (13) of the device. By loading the sealed vial into the barrel, any wastage or potentially harmful spillage of the drug is avoided. This also ensures that the patient dose is accurately known.
The depressable actuators (14) are depressed and the piercing means (15) pierces the seal of the vial (12) and releases the drug in the barrel (13). Figure 7 represents the piercing means (15) after piercing the vial seal.
Referring also to Figures 5 and 6, the patient places the mouth around the mouthpiece (16), which is at the end of a substantially right angle in the barrel, furthest from the depressable actuators. This position of the mouthpiece allows for administration of the drug to a patient in any physical position. The patient then inhales through the mouthpiece (16), inhalation made possible by inlet air vents included in the actuator portion (17).
Upon exhalation, any remaining drug is absorbed by the filter (18) in the outlet vents (not shown) in the actuator portion (17), thereby preventing escape of any drug into the environment of the patient and caregiver. Attachment of a strap (not shown in the Figures) is preferably on the side of the mouthpiece (20), opposite the air inlet (see Figure 6). The optional nozzle (19) for attachment of an oxygen hose is also shown in the Figures.
The many advantages of the device of the invention will be clear from the above discussion and from the Figures. The invention therefore provides a novel and efficient way of administering an inhalable drug in liquid form to a patient, without wastage or spillage of the drug, contamination of the surroundings, or discomfort to the patient. The device also provides a portable administration unit which is easy to operate, allowing a patient to self-administer should the need arise. The device can be disposable which improves the safety and reproducibility of administration of the drug. The foregoing embodiments are illustrative only of the principles of the invention, and various modifications and changes will readily occur to those skilled in the art. The invention is capable of being practiced and carried out in various ways and in other embodiments. It is also to be understood that the terminology employed herein is for the purpose of description and should not be regarded as limiting. The term "comprise" and variants of the term such as "comprises" or
"comprising" are used herein to denote the inclusion of a stated integer or stated integers but not to exclude any other integer or any other integers, unless in the context or usage an exclusive interpretation of the term is required.
Any reference to publications cited in this specification is not an admission that the disclosures constitute common general knowledge in Australia.
Claims
The claims defining the invention are as follows:
I . A device for facilitating inhalation of an inhalable drug in liquid form, the device comprising a barrel for holding a vial of the inhalable drug in liquid form, a piercing means substantially in the barrel, and a mouthpiece attached to an end of the barrel. 2. The device of claim 1 including a filter in communication with the mouthpiece.
3. The device of claim 1 wherein the drug is a volatile analgesic.
4. The device of claim 3 wherein the drug is a fluorocarbon-based analgesic.
5. The device of claim 1 wherein the barrel is a substantially straight tube.
6. The device of claim 1 wherein the barrel is a tube including a substantially right angled bend towards the mouthpiece.
7. The device of claim 1 wherein the device is disposable.
8. The device of claim 1 wherein the piercing means is a needle.
9. The device of claim 1 additionally including a means external of the barrel for moving the vial towards the piercing means or the piercing means towards the vial. 10. A method of providing an inhalable drug in liquid form comprising inserting a vial of the drug into the barrel of the device of claim 1 , piercing the seal of the vial with the piercing means enabling release of the drug, applying the mouthpiece to a subject wherein the subject inhales through the mouthpiece the released drug.
I 1. The method of claim 10 wherein the drug is a volatile analgesic. 12. The method of claim 10 wherein the piercing means is a needle.
13. The method of claim 10 wherein the seal of the vial is moved towards the piercing means.
14. The method of claim 10 wherein the piercing means is moved towards the seal of the vial. 15. The method of claim 14 wherein the piercing means is moved towards the seal of the vial by activation of at least one depressable actuator external to the barrel.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2008904085 | 2008-08-11 | ||
| AU2008904085A AU2008904085A0 (en) | 2008-08-11 | Inhaler |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2010017586A1 true WO2010017586A1 (en) | 2010-02-18 |
Family
ID=41668576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/AU2009/001029 Ceased WO2010017586A1 (en) | 2008-08-11 | 2009-08-11 | Inhaler with piercable vial and drug in liquid form |
Country Status (2)
| Country | Link |
|---|---|
| TW (1) | TW201010750A (en) |
| WO (1) | WO2010017586A1 (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017011865A1 (en) * | 2015-07-20 | 2017-01-26 | Medical Developments International Limited | Inhaler device for inhalable liquids |
| WO2018045418A1 (en) * | 2016-09-06 | 2018-03-15 | Medical Developments International Limited | Inhaler device for inhalable liquids |
| US10036574B2 (en) | 2013-06-28 | 2018-07-31 | British American Tobacco (Investments) Limited | Devices comprising a heat source material and activation chambers for the same |
| JP2018520833A (en) * | 2015-07-20 | 2018-08-02 | メディカル、ディベロップメンツ、インターナショナル、リミテッドMedical Developments International Limited | Inhaler device for inhalable liquid |
| US20190143053A1 (en) * | 2016-12-05 | 2019-05-16 | Microbase Technology Corp. | Aerosol generating apparatus with replaceable parts |
| US10542777B2 (en) | 2014-06-27 | 2020-01-28 | British American Tobacco (Investments) Limited | Apparatus for heating or cooling a material contained therein |
| US11064725B2 (en) | 2015-08-31 | 2021-07-20 | British American Tobacco (Investments) Limited | Material for use with apparatus for heating smokable material |
| US11241042B2 (en) | 2012-09-25 | 2022-02-08 | Nicoventures Trading Limited | Heating smokeable material |
| US11452313B2 (en) | 2015-10-30 | 2022-09-27 | Nicoventures Trading Limited | Apparatus for heating smokable material |
| US11659863B2 (en) | 2015-08-31 | 2023-05-30 | Nicoventures Trading Limited | Article for use with apparatus for heating smokable material |
| US11672279B2 (en) | 2011-09-06 | 2023-06-13 | Nicoventures Trading Limited | Heating smokeable material |
| US11825870B2 (en) | 2015-10-30 | 2023-11-28 | Nicoventures Trading Limited | Article for use with apparatus for heating smokable material |
| US11924930B2 (en) | 2015-08-31 | 2024-03-05 | Nicoventures Trading Limited | Article for use with apparatus for heating smokable material |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3565071A (en) * | 1968-09-19 | 1971-02-23 | Abbott Lab | Self-regulating therapeutic inhaler |
| US20020092520A1 (en) * | 2001-01-12 | 2002-07-18 | Casper Robert A. | Medicament respiratory delivery device and method |
| US20030034033A1 (en) * | 2000-06-30 | 2003-02-20 | Medihale Ltd. | System and method for aerosol delivery of a drug |
| WO2006125577A2 (en) * | 2005-05-24 | 2006-11-30 | Boehringer Ingelheim International Gmbh | Nebuliser |
| WO2007020073A1 (en) * | 2005-08-16 | 2007-02-22 | Pari Pharma Gmbh | Inhalation therapy device comprising an ampoule for holding a drug to be atomized |
| US20070119450A1 (en) * | 2003-09-24 | 2007-05-31 | Wharton David P | Medication holder |
-
2009
- 2009-08-11 WO PCT/AU2009/001029 patent/WO2010017586A1/en not_active Ceased
- 2009-08-11 TW TW98126889A patent/TW201010750A/en unknown
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3565071A (en) * | 1968-09-19 | 1971-02-23 | Abbott Lab | Self-regulating therapeutic inhaler |
| US20030034033A1 (en) * | 2000-06-30 | 2003-02-20 | Medihale Ltd. | System and method for aerosol delivery of a drug |
| US20020092520A1 (en) * | 2001-01-12 | 2002-07-18 | Casper Robert A. | Medicament respiratory delivery device and method |
| US20070119450A1 (en) * | 2003-09-24 | 2007-05-31 | Wharton David P | Medication holder |
| WO2006125577A2 (en) * | 2005-05-24 | 2006-11-30 | Boehringer Ingelheim International Gmbh | Nebuliser |
| WO2007020073A1 (en) * | 2005-08-16 | 2007-02-22 | Pari Pharma Gmbh | Inhalation therapy device comprising an ampoule for holding a drug to be atomized |
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11672279B2 (en) | 2011-09-06 | 2023-06-13 | Nicoventures Trading Limited | Heating smokeable material |
| US12041968B2 (en) | 2011-09-06 | 2024-07-23 | Nicoventures Trading Limited | Heating smokeable material |
| US11241042B2 (en) | 2012-09-25 | 2022-02-08 | Nicoventures Trading Limited | Heating smokeable material |
| US10036574B2 (en) | 2013-06-28 | 2018-07-31 | British American Tobacco (Investments) Limited | Devices comprising a heat source material and activation chambers for the same |
| US10542777B2 (en) | 2014-06-27 | 2020-01-28 | British American Tobacco (Investments) Limited | Apparatus for heating or cooling a material contained therein |
| JP7044702B2 (en) | 2015-07-20 | 2022-03-30 | メディカル、ディベロップメンツ、インターナショナル、リミテッド | Inhaler device for inhalable liquids |
| JP2018520833A (en) * | 2015-07-20 | 2018-08-02 | メディカル、ディベロップメンツ、インターナショナル、リミテッドMedical Developments International Limited | Inhaler device for inhalable liquid |
| US20210001060A1 (en) * | 2015-07-20 | 2021-01-07 | Medical Developments International Limited | Inhaler device for inhalable liquids |
| US11672925B2 (en) | 2015-07-20 | 2023-06-13 | Medical Developments International Limited | Inhaler device for inhalable liquids |
| US20180200459A1 (en) * | 2015-07-20 | 2018-07-19 | Medical Developments International Limited | Inhaler device for inhalable liquids |
| WO2017011865A1 (en) * | 2015-07-20 | 2017-01-26 | Medical Developments International Limited | Inhaler device for inhalable liquids |
| US11659863B2 (en) | 2015-08-31 | 2023-05-30 | Nicoventures Trading Limited | Article for use with apparatus for heating smokable material |
| US11064725B2 (en) | 2015-08-31 | 2021-07-20 | British American Tobacco (Investments) Limited | Material for use with apparatus for heating smokable material |
| US11924930B2 (en) | 2015-08-31 | 2024-03-05 | Nicoventures Trading Limited | Article for use with apparatus for heating smokable material |
| US11452313B2 (en) | 2015-10-30 | 2022-09-27 | Nicoventures Trading Limited | Apparatus for heating smokable material |
| US11825870B2 (en) | 2015-10-30 | 2023-11-28 | Nicoventures Trading Limited | Article for use with apparatus for heating smokable material |
| US12016393B2 (en) | 2015-10-30 | 2024-06-25 | Nicoventures Trading Limited | Apparatus for heating smokable material |
| US12219986B2 (en) | 2015-10-30 | 2025-02-11 | Nicoventures Trading Limited | Article for use with apparatus for heating smokable material |
| US11571526B2 (en) | 2016-09-06 | 2023-02-07 | Medical Developments International Limited | Inhaler device for inhalable liquids |
| WO2018045418A1 (en) * | 2016-09-06 | 2018-03-15 | Medical Developments International Limited | Inhaler device for inhalable liquids |
| US20190143053A1 (en) * | 2016-12-05 | 2019-05-16 | Microbase Technology Corp. | Aerosol generating apparatus with replaceable parts |
| US10994081B2 (en) * | 2016-12-05 | 2021-05-04 | Microbase Technology Corp. | Aerosol generating apparatus with replaceable parts |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201010750A (en) | 2010-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2010017586A1 (en) | Inhaler with piercable vial and drug in liquid form | |
| US6547764B2 (en) | Double pointed injection needle | |
| JP4943622B2 (en) | Insulin injection system having a disposable needle with both ends pointed and the disposable needle with both ends pointed | |
| JP5907969B2 (en) | Single-use device for cartridge drug delivery | |
| KR102574310B1 (en) | Inhaler device for inhalable liquids | |
| CN104780958B (en) | drug delivery device | |
| KR102574315B1 (en) | Inhaler device for inhalable liquids | |
| US8985113B2 (en) | Handheld therapeutic gas delivery | |
| JP2013505036A (en) | Drug delivery system and device having cap function | |
| JP2018518295A (en) | Drug delivery device | |
| CN108348702B (en) | Inhaler device for inhalable liquids | |
| CN109803702A (en) | Inhaler device for inhalable liquids | |
| CN102325556A (en) | drug delivery device | |
| TW201141566A (en) | Medicament delivery device | |
| CN115843263B (en) | Inhaler device for inhalable liquids | |
| US9345833B1 (en) | Dental instrument | |
| WO2008045369A2 (en) | Method and apparatus for delivering a drug | |
| CN108348705B (en) | Inhaler device for inhalable liquids | |
| CN120417994A (en) | Drug mixing system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09806229 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 09806229 Country of ref document: EP Kind code of ref document: A1 |